Balaxi Pharmaceuticals’ arm completes acquisition of 99% stake in BHES

08 Nov 2021 Evaluate

Balaxi Pharmaceuticals’ wholly owned subsidiary -- Balaxi Global DMCC, Dubai (BGD), has completed acquisition of 99% shares of Balaxi Healthcare El Salvador, S.A DE C.V, El Salvador, Central America (BHES), which has consequently become the step-down subsidiary of Balaxi Pharmaceuticals.

Balaxi Pharmaceuticals operates as an investment company in India.

Peers
Company Name CMP
Adani Enterprises 3040.90
Redington 213.50
Amrapali Industries 14.74
Rashi Peripheral 329.85
Compuage Infocom 4.36
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.